ROYAL BANK OF CANADA - TRACON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0264
-2.6%
0.00%
Q2 2023$0271
+1131.8%
0.00%
Q3 2022$0
-100.0%
22
-99.4%
0.00%
Q1 2022$11,0004,000
+399900.0%
0.00%
Q4 2019$010.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$16,344,0002.72%
Ikarian Capital, LLC 2,716,840$17,631,0001.42%
Telemetry Investments, L.L.C. 40,000$260,0000.36%
ACT CAPITAL MANAGEMENT, LLC 28,500$185,0000.10%
Vigilare Wealth Management 17,000$110,0000.07%
X-Square Capital, LLC 20,973$136,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 294,031$1,908,0000.06%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$545,0000.06%
NEA Management Company, LLC 346,718$2,250,0000.03%
GSA CAPITAL PARTNERS LLP 36,370$236,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders